Dextroamphetamine-Cocaine Behavioral Intervention - 5

D-amphetamine-Cocaine Behavioral Intervention

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000308

Enrollment

Registered

1999-09-21

Start date

1995-09-30

Completion date

2000-09-30

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine dependence

Brief summary

The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.

Interventions

DRUGDextroamphetamine

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

DRUGD-amphetamine

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

DRUGplacebo

placebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

Measure	Time frame
Verifiable cocaine abstinence	16 weeks of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026